Recommendation ID

What is the effectiveness of oral tacrolimus and systemic (intramuscular/subcutaneous/oral) methotrexate in the induction of remission in mild-to-moderate ulcerative colitis unresponsive to aminosalicylates?

Any explanatory notes
(if applicable)

To find out why the committee made the research recommendation on immunomodulators for unresponsive ulcerative colitis see rationale and impact.

Source guidance details

Comes from guidance
Ulcerative colitis: management
Date issued
May 2019

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 03/05/2019